Fire at GSK Pharma site, production disrupted
Mumbai: GlaxoSmithKline Pharmaceuticals Limited (GSK) has announced that a fire incident occurred at its contract manufacturing facility, resulting in temporary production disruption of operations at that site.
"We are assessing the impact and working closely with the site to expedite resumption of operations," the company stated in a BSE filing.
While GSK has not yet provided further details regarding the cause of the fire or any potential financial impact.
Read also: GSK Pharma names Sukanya Choudhury as Regulatory Head, Growth Emerging Markets
Next Story